Literature DB >> 29306066

Synthesis, molecular docking and biological evaluation of some benzimidazole derivatives as potent pancreatic lipase inhibitors.

Emre Menteşe1, Fatih Yılmaz2, Mustafa Emirik3, Serdar Ülker4, Bahittin Kahveci5.   

Abstract

In this study, a new series of benzimidazole and bisbenzimidazole derivatives were prepared via the reaction of iminoester hydrochlorides and o-phenylenediamines and then screened for their lipase inhibition properties. Among the synthesized molecules, compounds 7a, 8a and 8c showed the best inhibitory effect against lipase enzyme with IC50 values of 1.72 ± 0.12 µM, 1.92 ± 0.28 and 0.98 ± 0.07 µM, respectively. Moreover, molecular modeling studies were performed in order to understand to the inhibitory activity of the molecules. Binding poses of the studied compounds were determined at the target sites using induced fit docking (IFD) algorithms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Benzimidazole; Bisbenzimidazole; Lipase inhibition; Mebendazole; Molecular docking; Piperazine

Mesh:

Substances:

Year:  2017        PMID: 29306066     DOI: 10.1016/j.bioorg.2017.12.023

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors.

Authors:  Ebrahim Saeedian Moghadam; Abdullah Mohammed Al-Sadi; Meysam Talebi; Massoud Amanlou; Mohsen Amini; Raid Abdel-Jalil
Journal:  Daru       Date:  2022-01-18       Impact factor: 4.088

2.  Synthesis and Spectral Identification of Three Schiff Bases with a 2-(Piperazin-1-yl)-N-(thiophen-2-yl methylene)ethanamine Moiety Acting as Novel Pancreatic Lipase Inhibitors: Thermal, DFT, Antioxidant, Antibacterial, and Molecular Docking Investigations.

Authors:  Ismail Warad; Oraib Ali; Anas Al Ali; Nidal Amin Jaradat; Fatima Hussein; Lubna Abdallah; Nabil Al-Zaqri; Ali Alsalme; Fahad A Alharthi
Journal:  Molecules       Date:  2020-05-11       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.